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 Web table 1 Unadjusted mean change scores (Complete Case Cohort) 
Outcome 
Measure 
Range of 
scale 
Baseline 
Scores 
(n=759)*
Mean 
(SD) 
BL to ST Change ST to LT Change BL to LT Change 
TH 
(n=431) 
Mean Δ 
(SE)† 
UC 
(n=328) 
Mean Δ 
(SE)† 
Mean 
Diff. 
(SE)‡ 
Effect 
size¶ Sig. § 
TH 
(n=431) 
Mean Δ 
(SE)† 
UC 
(n=328) 
Mean Δ 
(SE)† 
Mean 
Diff. 
(SE)‡ 
Effect 
size¶ Sig. § 
TH 
(n=431) 
Mean Δ 
(SE)† 
UC 
(n=328) 
Mean Δ 
(SE)† 
Mean 
Diff. 
(SE)‡ 
Effect 
size¶ Sig. § 
PCS (US 
1998 NBS) 
scale 
0-100 33.44 
(11.14) 
0.15 
(0.39) 
+1.44 
(0.43) 
1.59 
(0.59) 
0.14 0.007 +0.40 
(0.35) 
+0.11 
(0.39) 
+0.30 
(0.53) 
0.03 0.576 +0.26 
(0.42) 
+1.55 
(0.48) 
1.30 
(0.63) 
0.12 0.041 
MCS (US 
1998 NBS) 
scale 
0-100 47.87 
(11.43) 
+1.30 
(0.53) 
+2.42 
(0.64) 
1.12 
(0.82) 
0.10 0.174 +0.14 
(0.41) 
0.78 
(0.53) 
+0.92 
(0.66) 
0.08 0.164 +1.44 
(0.55) 
+1.63 
(0.59) 
0.20 
(0.82) 
0.02 0.811 
EQ-5D 
scale 
0.59-
1.00 
0.58 (0.32) 0.01 
(0.01) 
+0.01 
(0.01) 
0.01 
(0.02) 
0.02 0.476 +0.01 
(0.01) 
+0.01 
(0.01) 
+0.00 
(0.02) 
0.00 0.973 +0.00 
(0.01) 
+0.02 
(0.02) 
0.01 
(0.02) 
0.03 0.480 
Brief STAI 
scale 
6-24 9.75 (3.66) 1.42 
(0.19) 
1.66 
(0.21) 
+0.24 
(0.28) 
0.07 0.390 +0.30 
(0.17) 
0.01 
(0.19) 
+0.31 
(0.26) 
0.08 0.228 1.12 
(0.19) 
1.67 
(0.22) 
+0.55 
(0.29) 
0.15 0.057 
CESD-10 
scale 
0-30 9.08 (5.94) 0.35 
(0.25) 
1.38 
(0.28) 
+1.03 
(0.38) 
0.17 0.006 0.05 
(0.22) 
+0.02 
(0.25) 
0.07 
(0.34) 
0.01 0.839 0.40 
(0.25) 
1.36 
(0.29) 
+0.96 
(0.39) 
0.16 0.013 
BL=baseline; ST=short term; LT=long term; TH=telehealth; UC=usual care; SD=standard deviation; MCID=minimally clinically important difference. 
Notes: 
*pooled across Intervention and Control arms. 
†calculated as earlier score - later score (i.e. a positive value indicates that the outcome was lower at the later time point; a negative value indicates that the outcome was 
higher at the later time point). 
‡calculated as TH mean Δ – UC mean Δ. 
§based on an Independent samples t-test. 
¶Universal or disease-specific minimal clinically importance differences (MCIDs) have not been established for these outcome measures. Interpretation of mean change 
scores (within trial arms) and mean differences in changes scores (between trial arms) is facilitated by reference to the baseline means and standard deviations shown in the 
table. For example, the mean difference in change scores for CESD-10 from BL to ST assessment is highly significant (p = 0.006) and can be interpreted as showing that TH 
participants show a smaller decrease in depressive symptoms at this assessment than UC participants. However, compared with the baseline mean and standard deviation of 
9.08 (5.94), the mean difference of 1.03 units on the CESD-10 scale is evidently modest. To further assist with the interpretation of mean differences the table includes a 
standardised effect size which transforms the mean difference from the original scale metric into standard deviation units. Effect size (Cohen’s d) is calculated using baseline 
SDs for only those participants included in each set of change analyses (i.e. BL to ST Change; ST to LT Change; BL to LT Change). This allows effect sizes to be 
meaningfully compared across outcomes. In lieu of established MCIDs for our outcomes we used Cohen’s d of 0.3 as the MCID; an effect size of this magnitude 
approximates Cohen’s definition of a ‘small’ (i.e. non trivial) effect 71. None of the observed mean differences in change scores reached this minimum threshold for clinical 
difference. 
